FDA Inspection
Delta Pharma, Inc.FDA Inspection 1292232 - Delta Pharma, Inc. - November 21, 2025
Record Details
This FDA Inspection record concerns Delta Pharma, Inc., with an inspection on November 21, 2025, issued by the New Orleans District Office, covering human drugs.
View Company Profile
ID · 80d920f8-4805-4a4a-bd47-6f597d08fdc2
Inspection Facts
- Inspection number
- 1292232
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.87Retest of approved components/containers/closures
- FDCA 503B(a)(10)(A)Drug product labels, fails to include
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Delta Pharma, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| April 12, 2024 | Not classified | New Orleans District Office | Drug Quality Assurance |
| June 2, 2023 | VAI | New Orleans District Office | |
| May 20, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 23, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 24, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Delta Pharma, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.